Loring Wolcott & Coolidge Fiduciary Advisors’s Haleon HLN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$8.86K Hold
950
﹤0.01% 525
2026
Q1
$9.35K Hold
950
﹤0.01% 520
2025
Q4
$9.9K Hold
950
﹤0.01% 496
2025
Q3
$8.9K Hold
950
﹤0.01% 504
2025
Q2
$9.85K Hold
950
﹤0.01% 482
2025
Q1
$9.72K Hold
950
﹤0.01% 484
2024
Q4
$9.1K Hold
950
﹤0.01% 490
2024
Q3
$9.4K Hold
950
﹤0.01% 500
2024
Q2
$8.31K Hold
950
﹤0.01% 499
2024
Q1
$7.94K Sell
950
-1,775
-65% -$14.8K ﹤0.01% 508
2023
Q4
$22.3K Sell
2,725
-7,416
-73% -$61.1K ﹤0.01% 454
2023
Q3
$80.7K Sell
10,141
-100
-1% -$833 ﹤0.01% 379
2023
Q2
$85.8K Buy
+10,241
New +$87.4K ﹤0.01% 382
2022
Q4
Sell
-9,830
Closed -$60K 590
2022
Q3
$60K Buy
+9,830
New +$63.6K ﹤0.01% 390

Other funds holding HLN

Loring Wolcott & Coolidge Fiduciary Advisors's HLN Position: Q2 2026 in Review

Loring Wolcott & Coolidge Fiduciary Advisors held its Haleon (HLN) position steady in Q2 2026 at 950 shares worth $8.86K. The position accounts for ﹤0.01% of the portfolio, ranked #525.

Loring Wolcott & Coolidge Fiduciary Advisors first reported a position in HLN in Q3 2022 and has held it in 14 quarters since. The position peaked at $85.8K in Q2 2023. 357 funds tracked by Wall St. Rank hold HLN as of Q2 2026.

  • Loring Wolcott & Coolidge Fiduciary Advisors held 950 shares of Haleon worth $8.86K as of Q2 2026.
  • Loring Wolcott & Coolidge Fiduciary Advisors left its Haleon share count unchanged in Q2 2026.
  • Haleon made up ﹤0.01% of Loring Wolcott & Coolidge Fiduciary Advisors's portfolio in Q2 2026, its #525 holding.
  • Loring Wolcott & Coolidge Fiduciary Advisors first reported a position in Haleon in Q3 2022 and has held it in 14 quarters since.
  • Loring Wolcott & Coolidge Fiduciary Advisors's Haleon position peaked at $85.8K in Q2 2023.
  • 357 funds tracked by Wall St. Rank held Haleon as of Q2 2026.

Based on Loring Wolcott & Coolidge Fiduciary Advisors's 13F filing for Q2 2026, filed 30 Jul 2026.